HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

15.630

+0.4202.76%

Volume:9.57M

Turnover:161.29M

Market Cap:6.75B

PE:2.37K

High:19.000

Open:16.780

Low:15.400

Close:15.210

52wk High:48.800

52wk Low:14.820

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:2.99

T/O Rate:2.96%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:3.94

PE(LYR):2,368.18

PS:13.38

Loading ...

Overview Company News Filings

CF PHARMTECH (02652) Repurchases 9,000 Shares for HK$164,000 on June 15

CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 18.26

CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%

Bulletin Express

CF PHARMTECH (02652) Allocates HK$968.9k for Share Buyback on June 11

CF Pharmtech files HKEX next-day disclosure return on share buyback at HKD 18.28 average price

CF PharmTech repurchases 14,500 H-shares; outstanding share count dips 0.0048%

Bulletin Express

CF PharmTech executes HKD 0.59 million share buyback; outstanding share count trimmed by 0.01%

Bulletin Express

Changfeng Pharmaceutical Executes Share Buyback on June 9

CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 19.14-high HKD 18.52-low

CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility

MT Newswires Live

CF PharmTech’s Suzhou Inhalation Facility Passes PIC/S GMP Inspection, Unlocking New International Market Potential

Bulletin Express

CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection

CF PHARMTECH Executes Share Buyback, Spending HK$684.3k

CF PHARMTECH Shares Surge Over 5% on Regulatory Green Light for New Drug Trial

CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million

Bulletin Express

CF PharmTech Sets 26 June AGM to Approve 2025 Results, Board Refresh, H-Share Incentive Expansion and Dual Capital Mandates

Bulletin Express

CF PHARMTECH (02652) Announces NMPA Approval for ICF004 Investigational New Drug Application

CF Pharmtech - Nmpa Approves Ind Application for ICF004 as Class 1 New Drug

THOMSON REUTERS

CF PharmTech Updates Board Structure and Committee Line-up

Bulletin Express

CF PHARMTECH (02652) Announces Proposed Nomination of Zhang Jingjing as Executive Director

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/02652/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":15.63,"timestamp":1787645294005,"preClose":15.21,"halted":0,"volume":9570100,"delay":0,"changeRate":0.02761341222879684,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Not Yet Opened","change":0.42,"latestTime":"08-25 16:08:14","open":16.78,"high":19,"low":15.4,"amount":161290098,"amplitude":0.236686,"askPrice":15.63,"askSize":1200,"bidPrice":15.51,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":15.21,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":2.987109058142811,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":2.987109058142811,"shares":432000000,"dividePrice":0,"high":19,"amplitude":0.236686,"preClose":15.21,"low":15.4,"week52Low":14.82,"pbRate":"3.94","psRate":"13.38","week52High":48.8,"institutionHeld":0,"latestPrice":15.63,"committee":-0.846154,"eps":0.0066,"divideRate":0,"volume":9570100,"delay":0,"ttmEps":0.006,"open":16.78,"prevYearClose":35,"prevWeekClose":15.2,"prevMonthClose":19.87,"prevQuarterClose":21,"fiveDayClose":16.74,"twentyDayClose":15.65,"sixtyDayClose":22.22,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-08-24","current":2605,"percent":0.558685,"low":-293.764894,"twenty":419.4266,"median":493.8281,"eighty":2823.760418,"high":3595.964728,"avg":1476.341179,"sd":1191.614833,"marketCap":6244942896},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082},{"date":"2026-08-24","current":2155.988187,"twenty":419.4266,"median":493.8281,"eighty":2823.760418,"marketCap":6244942896}],"updateTime":1787681589372},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1105116583","title":"CF PHARMTECH (02652) Repurchases 9,000 Shares for HK$164,000 on June 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1105116583","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105116583?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:29","pubTimestamp":1781526569,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced the repurchase of 9,000 of its own shares on June 15, 2026.The company executed the share buyback at a total cost of HK$164,000.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643037622","title":"CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 18.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2643037622","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643037622?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:22","pubTimestamp":1781526161,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 9,000 H shares on June 15, 2026 for treasury.Repurchase price range HKD 18.12 to HKD 18.4 per share; aggregate cost HKD 164,375.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL21MhW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107485359","title":"CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107485359","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107485359?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:44","pubTimestamp":1781264645,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. repurchased 14,000 H-shares on 12 June 2026 through on-market transactions in Hong Kong. The shares were bought at prices ranging from HKD 17.83 to HKD 18.15, with a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181094701","title":"CF PHARMTECH (02652) Allocates HK$968.9k for Share Buyback on June 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1181094701","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181094701?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:20","pubTimestamp":1781180458,"startTime":"0","endTime":"0","summary":"On June 11, CF PHARMTECH (02652) executed a share repurchase, utilizing HK$968,900 to acquire 53,000 of its own shares.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642628105","title":"CF Pharmtech files HKEX next-day disclosure return on share buyback at HKD 18.28 average price","url":"https://stock-news.laohu8.com/highlight/detail?id=2642628105","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642628105?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:15","pubTimestamp":1781180152,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 53,000 H shares on June 11, 2026 for treasury, with no shares repurchased for cancellation.Buyback price range HKD 17.84 to HKD 19.49; aggregate consideration HKD 968,900.Issued shares excluding treasury fell to 300,856,086; treasury shares rose to 1,367,500.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL5txsgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120748460","title":"CF PharmTech repurchases 14,500 H-shares; outstanding share count dips 0.0048%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120748460","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120748460?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:05","pubTimestamp":1781089538,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. reported a further share buyback on 10 June 2026, purchasing 14,500 H-shares on the Hong Kong Stock Exchange at prices between HK$18.10 and HK$18.34, with a volume-weighted average...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106329239","title":"CF PharmTech executes HKD 0.59 million share buyback; outstanding share count trimmed by 0.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106329239","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106329239?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:22","pubTimestamp":1781007766,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) reported a new on-market share repurchase on 09 June 2026 under its existing mandate. Key takeaways are as follows: • Transaction details: 31,000 H-shares were...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198234257","title":"Changfeng Pharmaceutical Executes Share Buyback on June 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1198234257","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198234257?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:15","pubTimestamp":1781007305,"startTime":"0","endTime":"0","summary":"Changfeng Pharmaceutical (CF PHARMTECH, SEHK: 02652) has announced a share repurchase transaction.The company disclosed that on June 9, 2026, it utilized HK$586,000 to buy back 31,000 of its own shares.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467642","title":"CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 19.14-high HKD 18.52-low","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467642","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467642?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:08","pubTimestamp":1781006932,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 31,000 H shares on June 9 for treasury, no shares cancelled.Buyback price range HKD 18.52 to HKD 19.14; aggregate consideration HKD 586,055.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL7wRHDs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641194425","title":"CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2641194425","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641194425?lang=en_us&edition=fundamental","pubTime":"2026-06-05 12:23","pubTimestamp":1780633427,"startTime":"0","endTime":"0","summary":"CF PharmTech  said its inhalation formulation production base in Suzhou passed a good manufacturing practice inspection conducted by the drug regulator of a member country of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, according to a Thursday Hong Kong bourse filing.The inspection covered the facility's production management and quality control systems, premises, equipment, data integrity, and computerized systems.Shares of the pharmaceutical firm were up over 1% in Friday morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","CF","LU0345780950.USD","LU0345781412.USD","BK1191","02652","LU0630314457.HKD","BK4585","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110397613","title":"CF PharmTech’s Suzhou Inhalation Facility Passes PIC/S GMP Inspection, Unlocking New International Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1110397613","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110397613?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:24","pubTimestamp":1780579454,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that its inhalation formulation production base in Suzhou has successfully passed an on-site Good Manufacturing Practice (GMP) inspection conducted by the drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153622309","title":"CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1153622309","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153622309?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:22","pubTimestamp":1780579349,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153929970","title":"CF PHARMTECH Executes Share Buyback, Spending HK$684.3k","url":"https://stock-news.laohu8.com/highlight/detail?id=1153929970","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153929970?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:06","pubTimestamp":1780578409,"startTime":"0","endTime":"0","summary":"On June 4, 2026, CF PHARMTECH (02652) announced it had repurchased 33,500 of its own shares.The total expenditure for this buyback transaction amounted to approximately HK$684,300.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159731974","title":"CF PHARMTECH Shares Surge Over 5% on Regulatory Green Light for New Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1159731974","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159731974?lang=en_us&edition=fundamental","pubTime":"2026-06-04 14:30","pubTimestamp":1780554629,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (SEHK: 02652) shares climbed more than 5% in trading. At the time of writing, the stock was up 5.55% to HK$21.3, with a turnover of HK$5.66 million.The recent price movement follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","IND","BK4585","BK1191","02652","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149956112","title":"CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1149956112","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149956112?lang=en_us&edition=fundamental","pubTime":"2026-06-03 17:05","pubTimestamp":1780477545,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026. • Registered capital remained unchanged at 411.98 million...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174360035","title":"CF PharmTech Sets 26 June AGM to Approve 2025 Results, Board Refresh, H-Share Incentive Expansion and Dual Capital Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1174360035","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174360035?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:03","pubTimestamp":1780412602,"startTime":"0","endTime":"0","summary":"CF PharmTech will convene its annual general meeting (AGM) on 26 June 2026 in Suzhou to seek shareholder approval on nine key resolutions that shape its next operating cycle and capital strategy. Key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122546310","title":"CF PHARMTECH (02652) Announces NMPA Approval for ICF004 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1122546310","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122546310?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:10","pubTimestamp":1780272631,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Investigational New Drug (IND) application for ICF004 inhalation powder, a Class I new drug, has recently been approved by China's National Medical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989785","title":"CF Pharmtech - Nmpa Approves Ind Application for ICF004 as Class 1 New Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640989785?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:00","pubTimestamp":1780272038,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42800I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175962402","title":"CF PharmTech Updates Board Structure and Committee Line-up","url":"https://stock-news.laohu8.com/highlight/detail?id=1175962402","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175962402?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:23","pubTimestamp":1780064609,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. released an announcement on 29 May 2026 detailing the latest composition of its Board of Directors and the three principal Board committees. The Board now comprises ten members....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159833172","title":"CF PHARMTECH (02652) Announces Proposed Nomination of Zhang Jingjing as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1159833172","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159833172?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:20","pubTimestamp":1780064419,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that Mr. Chen Penghui has resigned from his position as a non-executive director, effective May 29, 2026, due to his desire to dedicate more time to other...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":149,"code":"91000000","status":"200"}]}}